SB-T-1214 (SBT) is a taxane-based drug known for its ability to effectively suppress the expression of stem cell-related genes (Oct4, Sox2, and c-Myc) and induce apoptosis in drug-resistant tumorigenic CD133+/CD44+ colon cancer spheroids. In Pgp+ DLD-1 human colon tumor xenograft mouse models, SB-T-1214 successfully inhibits tumor growth. This compound is relevant for anti-tumor research, particularly against drug-resistant tumors such as colon, pancreatic, and renal cancers.
Molecular Weight:
853.95
CAS Number:
[178250-23-2]
Formula:
C45H59NO15
Target:
OCT|||Apoptosis|||c-Myc
T210736
* VAT and and shipping costs not included. Errors and price changes excepted
